Delays to UK Veterinary Medicine Regulatory Review means UK animals could miss out, says NOAH
13th December 2022
NOAH is frustrated by the latest UK Government delay to the public consultation on the new UK Veterinary Medicines Regulation (VMR).
Dawn Howard, NOAH Chief Executive, explained: “Our members’ UK animal health businesses continue in a climate of uncertainty which impacts on their ability to plan for investment here. They are operating under regulations based on a now-superseded EU Directive and are unable to benefit from the improvements to encourage innovation and drive down unnecessary administrative burden seen in other regions.
“The animal health industry provides technical expertise, R&D and innovation in the UK to protect people, animals and the environment; NOAH members need a regulatory framework that can enable the UK animal health sector to thrive. The opportunity is there, through the UK VMR review, for UK Government to support competitiveness and increase the availability of veterinary medicinal products to British livestock and companion animals.
“We call on the Government to stop the delays: to expedite the consultation to enable stakeholders to share views and then to bring forward revised legislation, so our sector can continue to provide the veterinary medicines needed to prevent and treat disease in the UK’s animals, helping secure our food supply, as well as supporting the Governments scientific ambitions through innovation in our sector.”
Notes for Editors
For more information contact firstname.lastname@example.org or see www.noah.co.uk
NOAH represents the UK animal health industry. We promote the benefits of licensed medicines and solutions for the health and welfare of all animals.